Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2017/02/11 08:58:39」(JST)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 孤立性髄外性形質細胞腫の診断およびマネージメント diagnosis and management of solitary extramedullary plasmacytoma
2. 原発性骨髄線維症の臨床症状および診断 clinical manifestations and diagnosis of primary myelofibrosis
3. 脊髄腫瘍 spinal cord tumors
4. サラセミアの臨床症状および診断 clinical manifestations and diagnosis of the thalassemias
5. 原発性骨髄線維症における病態 pathogenetic mechanisms in primary myelofibrosis

The role of polymorphisms of stromal-derived factor-1 and CXC receptor 4 in acute myeloid leukemia and leukemia cell dissemination.

Zheng Q1, Shuai X2, Ye Y1, Jin Y1, Jiang N1, Chen X1, Su J1.
Gene.Gene.2016 Aug 22;588(2):103-8. doi: 10.1016/j.gene.2016.04.059. Epub 2016 May 3.
BACKGROUND: Acute myeloid leukemia (AML) is a form of cancer characterized by infiltration of the bone marrow, blood, and other tissues by proliferative, clonal, abnormally differentiated cells of the hematopoietic system. Chemokine stromal cell-derived factor 1 (SDF-1) and its receptor CXC receptor
PMID 27154815

Presacral Myelolipoma: Diagnosis on Imaging With Pathologic and Clinical Correlation.

Lee JJ1, Dickson BC2, Sreeharsha B1, Gladdy RA3, Thipphavong S1.
AJR. American journal of roentgenology.AJR Am J Roentgenol.2016 Jun 1:1-12. [Epub ahead of print]
OBJECTIVE: Myelolipoma is a benign tumor composed of fatty and hematopoietic elements. Presacral myelolipoma is rare, with fewer than 40 cases reported in the English literature. It is important to make an accurate diagnosis because there are malignant diseases included in the differential diagnosi
PMID 27248571

Cunningham I1, Kohno B2.
American journal of hematology.Am J Hematol.2016 Jun;91(4):379-84. doi: 10.1002/ajh.24287. Epub 2016 Feb 9.
Extramedullary tumors remain an obstacle to curing more acute leukemia patients. Their incidence is unknown because the presence of occult tumors that contribute to relapse is not routinely sought as in other cancers. No standard approach exists for treating tumors at most sites, apparent clinical r
PMID 26718745